Tokyo, Japan
Tokyo, Japan

Time filter

Source Type

Patent
Teijin Pharma Ltd | Date: 2016-11-01

For reducing a discomfort feeling brought by wearing a breathing mask, a wearing tool for the breathing mask which covers nostrils of a user and supplies gas for breathing to the nostrils comprises a pair of connecting members each of which has a longitudinal shape and has a first end portion which is connected to the breathing mask, and a pair of fixing members each of which is connected to a second end portion of the fixing member and is plugged in the tragus of the user. Hence a discomfort feeling due to restraining around the head of the user can be reduced.


Patent
Teijin Pharma Ltd | Date: 2017-03-22

Provided is a novel pyrazine derivative represented by the following formula (I) or a pharmaceutically acceptable salt thereof, or a solvate thereof which is useful for treating or preventing diseases in which URAT1 is involved, including gout, hyperuricemia, hypertension, renal diseases such as interstitial nephritis and the like, diabetes, arteriosclerosis, Lesch-Nyhan syndrome, and the like.


Disclosed are crystals of 2-(5-chloropyridin-3-yl)-1-(2,5-dichlorobenzyl)-4-methyl-1H-imidazole-5-carboxylic acid useful as therapeutic or prophylactic agents for gout, hyperuricemia, and the like, and a method for producing the crystals.


Patent
Osaka City University and Teijin Pharma Ltd | Date: 2015-04-08

[PURPOSE] The invention provides a novel therapeutic agent or prophylactic agent for cognitive disorders. [SOLUTION MEANS] The invention provides an antibody that participates in antigen-antibody reaction specifically with tau protein that has been phosphorylated in the vicinity of Ser413 of SEQ ID NO: 1, and a therapeutic agent or prophylactic agent for cognitive disorders comprising as an active ingredient a peptide that has been phosphorylated in the vicinity of Ser413.


Patent
Teijin Ltd, Teijin Pharma Ltd and The Chemo Sero Therapeutic Research Institute | Date: 2015-03-25

A formed sheet product of a polymer composition comprising at least one protein selected from the group consisting of fibrinogen and thrombin and at least one polymer selected from the group consisting of an aliphatic polyester and a water-soluble polymer, and a laminated formed sheet product comprising a first polymer composition layer composed of fibrinogen and a water-soluble polymer and a second polymer composition layer composed of thrombin and an aliphatic polyester are provided. These formed products are applied onto a wound site and function as a hemostatic material.


Patent
Teijin Pharma Ltd | Date: 2016-06-03

The purpose of the present invention is to provide a novel therapeutic or prophylactic agent for tumor lysis syndrome. The present invention is a therapeutic or prophylactic agent for tumor lysis syndrome, which comprises a 2-phenylthiazole compound represented by formula (I) or a pharmaceutically acceptable salt thereof as an active ingredient.


Patent
Teijin Pharma Ltd | Date: 2016-02-03

Provided are a compound expressed by formula (I) or a pharmacologically permissible salt thereof, as well as a drug or drug composition that contains this compound as an active ingredient, having a xanthine oxidase inhibiting effect that is very useful for treating or preventing diseases that are contributed to by xanthine oxidase, such as gout, hyperuricemia, tumor lysis syndrome, urinary tract stones, hypertension, dyslipidemia, diabetes, cardiovascular disease such as heart failure and arterial sclerosis, renal disease such as diabetic near opacity and the like, respiratory disease such as chronic obstructive pulmonary disease and the like, autoimmune diseases such as inflammatory bowel disease, and the like. [In the formula, A, X, Y, Z, R, and R^(1) have the meaning set forth in claim 1.]


Patent
Teijin Pharma Ltd | Date: 2016-04-06

The present invention provides a gas supply apparatus (400) comprising: means (414) for detecting a users respiration; a product gas flow path on-off valve (412) having a function to start and stop output of the product gas in synchronization with the users respiration; and an ultrasonic type gas concentration and flow rate measuring means (410) having two ultrasonic transducers (420) disposed in an opposed manner in the line (422) through which the product gas flows, wherein a concentration value measured when said product gas output is stopped is determined to be a product gas concentration. As the oxygen concentration is measured while the output of the product gas flow is stopped in synchronization with the users respiration, even in the respiratory synchronous type gas supply apparatus, the ultrasonic type gas concentration and flow rate measuring means can measure the oxygen concentration of the product gas accurately.


Patent
Teijin Pharma Ltd | Date: 2016-02-10

Provided is a magnetic stimulation device, which does not feel hot to the user. The magnetic stimulation device (1) comprises: a contact plate (2) to be disposed near the users head; an exciting coil (3) to be held above the contact plate (2) ; a casing (4), which covers at least the upper side of the exciting coil (3), in which openings (17, 18) are provided above the center of the exciting coil (3) winding, and in which a gap that is open on the outside of the exciting coil (3) is formed between the casing and the contact plate (2) ; and a suction fan (5) for drawing out air between the contact plate (2) and the casing (4) from the openings (17, 18) of the casing (4).


Provided is an inexpensive device capable of accurately positioning a medical instrument relative to the head of a user. A head positioning device (7) is used. The head positioning device (7) is provided with: a pair of holding members (11, 12) which holds the face of a user from both sides by elasticity and prevents both the forward tilting of the users head and the rotation of the neck; a neck rest (13) which comes into contact with the back side of the users neck and determines the position of the neck in the front-rear direction; and a head-back rest (14) which comes into contact with the back of the head and which prevents the head from tilting backward.

Loading Teijin Pharma Ltd collaborators
Loading Teijin Pharma Ltd collaborators